EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Eculizumab in treatment for complement-mediated thrombotic microangiopathy associated with acute pancreatitis

Shruti Shettigar, Rutvikkumar Jadvani, Dwij Doshi, Chintan V Shah

EXCLI Journal · 18.12.2025 · 24 · 1802-1803

DOI: 10.17179/excli2025-8881 ↗

Kurz gefasst

Leserbrief in der Zeitschrift EXCLI Journal, online erschienen am 18.12.2025. Verfasst von Shruti Shettigar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida -College of Medicine, Gainesville, Florida, USA. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida -College of Medicine, Gainesville, Florida, USA.
  • Rahul International School, Mira Road, Thane, Maharashtra, India.

Zitieren

APA

Shettigar, S., Jadvani, R., Doshi, D., & Shah, C. V. (2025). Eculizumab in treatment for complement-mediated thrombotic microangiopathy associated with acute pancreatitis. EXCLI Journal, 24, 1802-1803. https://doi.org/10.17179/excli2025-8881

Vancouver

Shettigar S, Jadvani R, Doshi D, Shah CV. Eculizumab in treatment for complement-mediated thrombotic microangiopathy associated with acute pancreatitis. EXCLI Journal. 2025;24:1802-1803. doi:10.17179/excli2025-8881

BibTeX
@article{Shettigar2025,
  author = {Shettigar, Shruti and Jadvani, Rutvikkumar and Doshi, Dwij and Shah, Chintan V},
  title = {Eculizumab in treatment for complement-mediated thrombotic microangiopathy associated with acute pancreatitis},
  journal = {EXCLI Journal},
  year = {2025},
  volume = {24},
  pages = {1802--1803},
  doi = {10.17179/excli2025-8881}
}
Kostenlos starten →